Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical basic fibroblast growth factor plus heparin for split-thickness skin graft donor site healing
jRCT1041230082Recruiting
- Start
- Aug 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in split-thickness skin graft donor site wound comparing Standard bFGF + white petrolatum with bFGF solution + heparin ointment (2 arms). Primary endpoint: Epithelialized area at 4 weeks. Started Aug 2020; status: recruiting.
02
Drugs
traferminheparin
03
Conditions
split-thickness skin graft donor site wound
Beyond the preview
Go deeper on jRCT1041230082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230082.